New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 1, 2024 - Biocon announced the FDA approval of Yesintek (ustekinumab-kfce), biosimilar to Janssen’s Stelara® (ustekinumab).
Download PDF
Return to publications
